Ardelyx Inc (ARDX) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Ardelyx inc   (NASDAQ: ARDX)
 

Ardelyx Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Ardelyx Inc 's inventory turnover ratio sequentially decreased to 0.5 in the second quarter 2026, unsurprisingly, as the Ardelyx Inc markets continue to deteriorate, and ARDX's faces growing challenges to bring down its inventories. Ardelyx Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 730 days, from 250 days, in the Mar 31 2026 quarter.

Within Healthcare sector 352 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1727, from total ranking in the first quarter 2026 at 1835.

ARDX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Ardelyx Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARDX Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 523.95 % -4.34 % -16.24 % 121.23 % 61.93 %
Y / Y Cost of Sales Growth -53.57 % -60.9 % -40.6 % -74.68 % 31.44 %
Inventory Turnover Ratio (TTM) 0.5 1.46 1.78 2.03 2.99
ARDX's Total Ranking # 1727 # 1835 # 1577 # 1256 # 1202
Average inventory processing period 735 250 205 180 122
Seq. Inventory Growth 511.06 % 28.25 % -29.54 % 13.01 % -6.31 %
Seq. Cost of Sales Growth 19.7 % -55.65 % 172.45 % -67.89 % 0.81 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 111
Healthcare Sector # 353
Overall Market # 1727

Inventory Turnover Ratio Statistics
High Average Low
3.6 1.87 0.5
(Dec 31 2024)   (Jun 30 2026)



ARDX Company Profile >> Back to ARDX Efficiency Comparisons >> Compare ARDX Inventory Turnover Ratio to its Competitors

Financial Statements
Ardelyx Inc 's Inventories $ 139 Millions Visit ARDX's Balance sheet
Ardelyx Inc 's Cost of Revenues TTM $ 25 Millions Visit ARDX's Income Statement
What are ARDX's Sales? Visit ARDX's Sales by Segment

Other Inventory Turnover Ratios
Ardelyx Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ARDX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ARDX's Competitors
Inventory Turnover Ratio for ARDX's Suppliers
Inventory Turnover Ratio for ARDX's Customers

You may also want to know
ARDX's Sales Growth Rates ARDX's Pe Price to earnings ratio ARDX's Receivables Turnover Ratio ARDX's Stock Quote
ARDX's Net Income Growth Rates ARDX's Ps Price to Sales ratio ARDX's Sales per Employee ARDX's Asset Turnover Ratio
ARDX's Net Margin ARDX's Pb Price to Book ratio ARDX's Financial Strength Ratios ARDX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Ardelyx inc   0.50 $ 25.401  Millions$ 51  Millions
Orthopediatrics Corp  0.49 $ 65.142  Millions$ 134  Millions
Scienture Holdings Inc   0.47 $ 0.101  Millions$ 0  Millions
Co diagnostics Inc   0.44 $ 0.412  Millions$ 1  Millions
Immunitybio inc   0.43 $ 1.095  Millions$ 3  Millions
Pelthos Therapeutics Inc   0.40 $ 9.271  Millions$ 23  Millions
EBR Systems, Inc.  0.39 $ 5.514  Millions$ 14  Millions
Aspire Biopharma Holdings Inc   0.34 $ 0.080  Millions$ 0  Millions
Guided Therapeutics Inc   0.32 $ 0.158  Millions$ 1  Millions
Invo Fertility Inc   0.29 $ 0.065  Millions$ 0  Millions
Outlook Therapeutics Inc   0.26 $ 0.985  Millions$ 4  Millions
Alpha Cognition Inc.  0.23 $ 1.250  Millions$ 6  Millions
Verrica Pharmaceuticals Inc   0.17 $ 0.400  Millions$ 2  Millions
Nexalin Technology Inc   0.17 $ 0.030  Millions$ 0  Millions
Femasys Inc   0.15 $ 0.898  Millions$ 6  Millions
Yubo International Biotech Limited  0.15 $ 0.004  Millions$ 0  Millions
Bioadaptives Inc   0.14 $ 0.006  Millions$ 0  Millions
Citius Pharmaceuticals Inc   0.07 $ 1.610  Millions$ 22  Millions
Adagio Medical Holdings inc   0.05 $ 0.089  Millions$ 2  Millions
Citius Oncology Inc  0.04 $ 0.821  Millions$ 21  Millions

Date modified: 2026-09-08T16:35:06+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.